Our OsteoSurge® 100 grafts combine demineralized bone matrix with patented Accell® Bone Matrix in a bio-resorbable, reverse-phase medium carrier. Provided in a syringe, the putty is moldable and resists irrigation. The putty may be implanted directly from the syringe.
Key Features & Technologies
Focused on the details.
- Accell Technology - The patented Accell process yields Accell bone matrix (ABM). ABM is an open-structured, dispersed form of DBM
- Superior Handling - The unique, poloxamer, reverse phase medium carrier, which becomes more viscous at body temperature, provides exceptional handling and containment characteristics. The graft is moldable, packable, mixable and resists irrigation
- Verified Osteoinductive Potential - Every lot of DBM is tested in a validated, in vitro assay to verify osteoinductive potential
- Expert Processing - Ground cortical bone and cancellous bone obtained from AATB-accredited tissue banks is processed into DBM in our state-of-the-art facility. The demineralization process is tightly controlled to consistently produce demineralized bone
- Electron Beam Sterilization - The processing of DBM and ABM is completed under aseptic conditions in our state-of-the-art facility. As the last step in manufacturing, the graft is sterilized via electron beam irradiation